| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.31 | 2e-12 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.29 | 9e-12 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.29 | 3e-08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.061 | 0.1 |